Medical Discoveries | Pharma Voice | Experimental | Safety Innovations | Certifications & Approvals | Laboratories
Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand
Lumen plots site at nearby Seattle bakery as it ramps up production of algae-based biologics
Takeda lays out $126M to tap robotics, virtual reality and more at California production site
Fierce Pharma Asia—Junshi’s mRNA JV; Novartis’ China business; Roche’s Ronapreve COVID nod in Japan
J&J’s COVID-19 shot scores safety backing from CDC experts but booster need left for FDA
CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation
Biogen execs blame critics, the media for spurring ‘misinformation’ as Aduhelm launch lags expectations
Trade group trio raises drug shortage alarm as FDA ups its carcinogen testing efforts
CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation
Solabia-Algatech Nutrition Launches Whole-Algae Sourced β-glucan
NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), a Kentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by
To unlock the potential of biologics, Seattle, Washington-based startup Lumen Bioscience turned to a blue-green algae most popular in recent years as a dietary supplement. With three
After recently opening one cell therapy plant and breaking ground on another in Massachusetts, Takeda is pivoting westward to beef up production in California. The Japanese
The UK’s National Institute for Health and Care Excellence (NICE) and Public Health England (PHE) have published a new jointly developed guideline on antimicrobial prescribing
China’s Junshi Biosciences has formed an mRNA-focused joint venture with delivery specialist Immorna. Novartis touts strong growth in China as the Swiss pharma looks to
NHS England has set out plans to improve patient access to mental health services with a proposal to introduce five new waiting time guarantees. The
Microbiome therapeutics company Seres Therapeutics has announced that a Phase IIb study of its potential ulcerative colitis (UC) candidate SER-287 failed to meet its primary
AstraZeneca (AZ) has announced that new real-world data from Canada shows its COVID-19 vaccine – Vaxzevria – was found to be highly effective after one
Johnson & Johnson’s COVID-19 vaccine presents greater benefits than it does safety risks, especially amid the quickly spreading Delta variant, a key CDC expert panel
On 9 November 2021, the 18th Annual CPhI Pharma Awards will take place in Milan, Italy at the Stella Polare Convention Centre. The CPhI Pharma
